Skip to main content
Log in

A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The use of luteal phase support has been demonstrated in patients undergoing IVF/ET in cycles stimulated after pituitary desensitization with gonadotrophin releasing hormone agonists. However, it is still not clear which is the most suitable kind of supplementation. This study was designed to compare the absorption and the efficacy of three different luteal support. We randomly administered progesterone i.m. (50 mg/day), human chorionic gonadotrophin (hCG) (2000 IU every three days), progesterone vaginal cream (100 mg/day) or nothing (controls) to 176 women treated for assisted procreation. We were not able to show any statistical differences for the percentage of pregnancy rate between groups. The serum progestrerone (P) and 17-ß-estradiol (E2) and E2/P ratio levels of the luteal phase were compared with the control not supplemented group. All the treatments were able to increase significantly the luteal P values versus controls (p<0.01). Moreover, vaginal cream and natural P im significantly decreased E2/P ratio (p<0.05). Serum P levels were more steady with P vaginal cream than im injection. Vaginal cream for better bioavailability and acceptance appear the most suitable and comfortable method for luteal phase support.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Csapo A.I., Pulkkinen M.O., Ruttner B., Sauvage J.P., Wiest W.G. The significance of human corpus luteum in pregnancy maintenance. Am. J. Obstet. Gynecol. 112: 1061, 1972.

    CAS  PubMed  Google Scholar 

  2. Li T.C., Cooke L.D. Evaluation of luteal phase. Hum. Reprod. 6: 484, 1991.

    CAS  PubMed  Google Scholar 

  3. Jones G.S. The luteal phase defect. Fertil. Steril. 27: 351, 1975.

    Google Scholar 

  4. Huang K.E., Muechler E.K., Schwartz F.K., Goggin M., Graham M. Serum progesterone levels in women treated with human menopausal gonadrotopin and human chorionic gonadotropin for in vitro fertilization. Fertil. Steril. 46: 903, 1986.

    CAS  PubMed  Google Scholar 

  5. Daya S. Efficacy of progesterone support in the luteal phase following in vitro fertilization and embryo transfer: metaanalysis of clinical trials. Hum. Reprod. 3: 731, 1988.

    CAS  PubMed  Google Scholar 

  6. Smitz J., Devroey P., Braekmans P., Camus M., Khan I., Staessen C., Van Waesberghe L., Wisanto A., Van Steirtenghem A.C. Management of failed cycles in IVF/GIFT program with the combination of a GnRH analogue and HMG Hum. Reprod. 2: 309, 1987.

    CAS  Google Scholar 

  7. Smitz J., Devroey P., Camus M., Deshacht J., Khan I., Staessen C., Van Waesberghe L., Wisanto A., Van Steirteghem A.C. The luteal phase and early pregnancy after combined GnRH agonist/HMG tretment for superovulation in IVF or GIFT. Hum. Reprod. 3: 585, 1988.

    Article  CAS  PubMed  Google Scholar 

  8. Kubik C.J. Luteal phase dysfunction following ovulation induction. Semin. Reprod. Endocrinol. 4: 293, 1986.

    Article  Google Scholar 

  9. Van Steirteghem A.C., Smitz J., Camus M., Van Waesberghe L., Deschacht J., Khan I., Staessen C., Wisanto A., Bourgain C., Devroey P. The luteal phase after in vitro fertilization and related procedures. Hum. Reprod. 3: 161, 1988.

    PubMed  Google Scholar 

  10. Macnamee M.C., Edwards R.G., Howies C.M. The influence of stimulation regimens and luteal phase support on the outcome of IVF. Hum. Reprod. 3: 43, 1988.

    Article  PubMed  Google Scholar 

  11. Smith E.M., Anthony F.W., Gadd S.C., Masson G.M. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. Br. Med. J. 298: 1483, 1989.

    Article  CAS  Google Scholar 

  12. Belaisch-Allart J., De Mouzon J., Lapouterle C., Mayer M. The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme. Hum. Reprod. 5: 163, 1990.

    CAS  PubMed  Google Scholar 

  13. Gidley—Baird A.A., O’Neill C., Sinosich M.J., Porter R.N., Pike I.L., Suanders D.M. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effect of altered progesterone/estrogen ratios in human and mice. Fertil. Steril. 45: 69, 1986.

    PubMed  Google Scholar 

  14. Smitz J., Devroey P., Van Steirteghem A.C. Endocrinology in luteal phase and implantation. Br. Med. Bull. 46: 709, 1990.

    CAS  PubMed  Google Scholar 

  15. Lejeune B., Camus M., Deschact J., Leroy F. Differences in the luteal phases after failed or succesfull in vitro fertilization and embryo replacement. J. Vitro Fert Embryo Transfer. 3: 358, 1986.

    Article  CAS  Google Scholar 

  16. Buvat J., Marcolin G., Herbaut J.C., Dehaene J.L., Verbeck P., Fourlinnie J.C. A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer. Fertil. Steril. 49: 458, 1988.

    CAS  PubMed  Google Scholar 

  17. Latouche J., Crumeyrolles—Arias M., Jordan D., Kopp N., Augendre-Ferrante B., Cedard L., Haour F. GnRH receptors in human granulosa cells:anatomical localization and characterization by autoradiographic study. Endocrinology 125: 1739, 1989.

    Article  CAS  PubMed  Google Scholar 

  18. Dehou M.F., Lejeune B., Arijs C., Leroy F. Endometrial morphology in stimulated in vitro fertilisation cycles and after steroid replacement therapy in cases of primary ovarian failure. Fertil. Steril. 48: 995, 1987.

    CAS  PubMed  Google Scholar 

  19. Brzyski R.G., Hofmann G.E., Scott R.T., Jones H.W. Effects of leuprolide acetate on follicular fluid hormone composition at oocyte retrieval for in vitro fertilization. Fertil. Steril. 54: 842, 1990.

    CAS  PubMed  Google Scholar 

  20. Yovich J.L., McColm S.C., Yovich J.M., Matson P.L. Early luteal serum progesterone concentrations are higher in pregnancy cycles. Fertil. Steril. 44: 185, 1985.

    CAS  PubMed  Google Scholar 

  21. Smitz J., Camus M., Devroey P., Erard P., Wisanto A., Van Steirteghem A.C. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/hMG superovulation for in vitro fertilization. Hum. Reprod. 5: 933, 1990.

    CAS  PubMed  Google Scholar 

  22. Lindner C., Braendle W., Kohler S., Bettendorf G. Higher incidence of ovarian hyperstimulation syndrome after combined GnRH-Agonist-HMG therapy. Geburtshilfe Frauenheilkd. 49: 337, 1989.

    Article  CAS  PubMed  Google Scholar 

  23. Herman A., Ron-El R., Golan A., Raziel A., Soffler Y., Caspi E. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotrophin in in vitro fertilization stimulated with gonadotrophin-releasing hormone analog and menotropins. Fertil. Steril. 53: 92, 1990.

    CAS  PubMed  Google Scholar 

  24. Antoine J.M., Salat-Baroux J., Alvarez S., Cornet D., Tibi C., Mandelbaum J., Plachot M. Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in vitro fertilization: a prospective randomized comparison. Hum. Reprod. 5: 565, 1990.

    CAS  PubMed  Google Scholar 

  25. Garcia J., Jones C., Acosta A., Wright G. Corpus luteum function after follicle aspiration for oocyte retrieval. Fertil. Steril. 36: 565, 1981.

    CAS  PubMed  Google Scholar 

  26. Halme J., Hammond M.G., Syrop C.H., Talbert L.M. Peritoneal macrophages modulate granulosa luteal cell progesterone production. J. Clin. Endocrinol. Metab. 61: 912, 1985.

    Article  CAS  PubMed  Google Scholar 

  27. Kinel F.A., Ciaccio L.A. Suppression of immune response by progesterone. Endocrinol. Exp. 14: 27, 1980.

    Google Scholar 

  28. Smitz J., Devroey P., Faguer P., Bourgain C., Camus M., Van Steirteghem A.C. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum. Reprod. 7: 168, 1992.

    Article  CAS  PubMed  Google Scholar 

  29. Enry R., Simoncini C., Chastelliere N., Lignieres B. Variations de la progesterone plasmatique induites par l’administration vaginale d’Utrogestan. J. Gynecol. Obstet. Biol. Reprod. 18: 229, 1989.

    Google Scholar 

  30. Devroey P., Palermo G., Bourgain C., Van Waesberghe L., Smitz J. Progesterone administration in patients with absent ovaries. Int. J. Fertil. 34: 188, 1989.

    CAS  PubMed  Google Scholar 

  31. Bourgain C., Devroey P., Van Waesberghe L., Smitz J., Van Steirteghem A.C. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum. Reprod. 5: 537, 1990.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Artini, P.G., Volpe, A., Angioni, S. et al. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 18, 51–56 (1995). https://doi.org/10.1007/BF03349699

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349699

Key-words

Navigation